Mereo BioPharma Group plc
MREO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719714
No open-market purchases or sales by Mereo BioPharma Group plc insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $18.0M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Mereo BioPharma Group plc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 53 | 1 | 56 | +4 |
| Shares | 64.5M | 1.55M | 70.5M | +7.56M (+12.0%) |
| Value | $84.3M | $2.05M | $90.4M | +$8.17M (+9.9%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Mereo BioPharma Group plc at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Soleus Capital Management, L.P. | 9,677,419 | $12.5M | 1.26% |
| Adage Capital Partners GP, L.L.C. | 800,000 | $1.03M | 0.00% |
| Formidable Asset Management, LLC | 331,914 | $428.2K | 0.09% |
| Susquehanna International Group, LLP | 103,270 | $133.2K | 0.00% |
| NEOS Investment Management LLC | 41,328 | $53.3K | 0.01% |
| Virtu Financial LLC | 34,093 | $44.0K | 0.00% |
| Creative Planning | 15,820 | $20.4K | 0.00% |
| Arcus Capital Partners, LLC | 15,000 | $19.4K | 0.01% |
| XTX Topco Ltd | 11,313 | $14.6K | 0.00% |
| Highlander Capital Management, LLC | 127 | $0 | 0.00% |
Sold out (6)
Institutions that held Mereo BioPharma Group plc at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Baker Bros. Advisors LP | 3,554,979 | $4.69M |
| Boxer Capital, LLC | 2,250,000 | $2.97M |
| Envestnet Asset Management Inc | 74,727 | $98.6K |
| Newbridge Financial Services Group, Inc. | 9,500 | $12.5K |
| UBS Group AG | 2,491 | $3.29K |
| Royal Bank of Canada | 14 | $0 |
Not filed for Q3 2023 yet (1)
Institutions that held Mereo BioPharma Group plc at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tekla Capital Management LLC | 1,551,082 | $2.05M |